Abstract

PurposeTo establish a non-invasive diagnostic model based on convolutional neural networks (CNNs) to distinguish benign from malignant lesions manifesting as a solid, indeterminate solitary pulmonary nodule (SPN) or mass (SPM) on computed tomography (CT).MethodA total of 459 patients with solid indeterminate SPNs/SPMs on CT were ultimately included in this retrospective study and assigned to the train (n=366), validation (n=46), and test (n=47) sets. Histopathologic analysis was available for each patient. An end-to-end CNN model was proposed to predict the natural history of solid indeterminate SPN/SPMs on CT. Receiver operating characteristic curves were plotted to evaluate the predictive performance of the proposed CNN model. The accuracy, sensitivity, and specificity of diagnoses by radiologists alone were compared with those of diagnoses by radiologists by using the CNN model to assess its clinical utility.ResultsFor the CNN model, the AUC was 91% (95% confidence interval [CI]: 0.83–0.99) in the test set. The diagnostic accuracy of radiologists with the CNN model was significantly higher than that without the model (89 vs. 66%, P<0.01; 87 vs. 61%, P<0.01; 85 vs. 66%, P=0.03, in the train, validation, and test sets, respectively). In addition, while there was a slight increase in sensitivity, the specificity improved significantly by an average of 42% (the corresponding improvements in the three sets ranged from 43, 33, and 42% to 82, 78, and 84%, respectively; P<0.01 for all).ConclusionThe CNN model could be a valuable tool in non-invasively differentiating benign from malignant lesions manifesting as solid, indeterminate SPNs/SPMs on CT.

Highlights

  • With the use of thoracic low-dose computed tomography (CT) for lung cancer screening, an increasing number of solitary pulmonary nodules (SPNs) or masses (SPMs) are deliberately or incidentally discovered

  • While there was a slight increase in sensitivity, the specificity improved significantly by an average of 42%

  • The cascade convolutional neural network (CNN) model could be a valuable tool in non-invasively differentiating benign from malignant lesions manifesting as solid, indeterminate SPNs/solitary pulmonary masses (SPMs) on CT

Read more

Summary

Introduction

With the use of thoracic low-dose computed tomography (CT) for lung cancer screening, an increasing number of solitary pulmonary nodules (SPNs) or masses (SPMs) are deliberately or incidentally discovered. Solid SPNs are extremely common, and malignancy account for approximately 60% (range: 55–66%) [1, 2]. Data from the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial indicated that SPMs were highly predictive of malignancy (odds ratio, 10.3; 95% confidence interval [CI], 2.46– 43.38) [3]. Solid malignant lesions are related to rapid cancer growth and high risks of recurrence and metastasis, despite their small size [4, 5]. Surgery is the diagnostic gold standard and definitive treatment for malignant cases. 25–46% of patients with SPNs have benign disease despite a preoperative suspicion of cancer, and an incorrect diagnosis results in unnecessary invasive resection and monetary and time costs [6, 7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call